Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
about
An oncogenic role for sphingosine kinase 2.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Sphingosine-1-phosphate modulators in inflammatory skin diseases - lining up for clinical translation.Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.Mast cells and sphingosine-1-phosphate underlie prelesional remodeling in a mouse model of eczema.Colonic migrating motor complexes are inhibited in acute tri-nitro benzene sulphonic acid colitis.
P2860
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@en
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@nl
type
label
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@en
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@nl
prefLabel
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@en
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
@nl
P2093
P2860
P356
P1476
Topical Application of Fingolimod Perturbs Cutaneous Inflammation
@en
P2093
Claudine S Bonder
David P Dimasi
Melissa R Pitman
Michele A Grimbaldeston
Robert Heddle
P2860
P304
P356
10.4049/JIMMUNOL.1501510
P407
P577
2016-03-21T00:00:00Z